Gema Diagnostics' Series A Round

Gema Diagnostics raised a round of funding on January 01, 2006. Investors include North Coast Technology Investors.

Gema Diagnostics aims to raise IVF birth rates by giving clinicians tools to select the most competent eggs (oocytes) and most viable embryos. GemART, the company's first clinical test, will identify …

Articles about Gema Diagnostics' Series A Round: